Horizon Blue Cross Blue Shield (BCBS) of New Jersey updates the SRS/SBRT coverage policy to include prostate cancer

The CyberKnife Coalition (CKC) is pleased to share some important and
exciting changes in regional private payer coverage for CyberKnife.
Effective September 18, 2012, Horizon Blue Cross Blue Shield (BCBS) of
New Jersey will cover SBRT to treat prostate cancer.

Background

Horizon BCBS covers approximately 3.4 million lives and is the largest
private payer in the state of New Jersey. With this change, the top 3
private payers in the state of New Jersey (1. Horizon BCBS, 2. Aetna , 3.
Cigna), along with Medicare, cover CyberKnife for the treatment of
prostate cancer.

Policy and Coverage Information

Horizon BCBS’s updated coverage policy can be found at the following
web address: https://services3.horizon-bcbsnj.com/hcm/MedPol2.nsf.
Within the Medical Policy Manual section of website, please search for
the “Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy”
coverage policy.

We look forward to continuing our work with our member centers and the
payer community to ensure that all appropriate patients have access to the
CyberKnife technology.